共 45 条
[1]
Petrosillo, Puro, Ippolito, The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis, Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients, 64, pp. 636-639, (1993)
[2]
Alter, Favero, Maynard, Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States, J Infect Dis, 153, pp. 1149-1151, (1986)
[3]
Alter, Favero, Moyer, Miller, Bland, National surveillance of dialysis-associated diseases in the United States, 1988, ASAIO Trans, 36, pp. 107-118, (1990)
[4]
Favero, Preventing transmission of hepatitis B in health care facilities, Am J Infect Control, 17, pp. 168-171, (1989)
[5]
Parsa, Infection in patients on dialysis, Human immunodeficiency virus (HIV) infection and the kidney, 112, pp. 40-45, (1990)
[6]
Mondelli, Cristina, Piazza, Cerino, Villa, Salvadeo, High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay, Nephron, 61, pp. 350-351, (1992)
[7]
Besso, Rovere, Peano, Et al., Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit, Nephron, 61, pp. 304-306, (1992)
[8]
Franco, Olivadese, Valeri, Albertoni, Petrosillo, Control of hepatitis B virus infection in dialysis units in Latium, Italy, Nephron, 61, pp. 329-330, (1992)
[9]
Petrosillo, Scaccia, Puro, Ippolito, Hepatitis C transmission in dialysis, Nephron, 63, (1993)
[10]
Cariani, Zonaro, Primi, Et al., Detection of HCV RNA and antibodies to HCV after needlestick injury, Lancet, 337, (1991)